STE
NYSESTERIS plc
Technology · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Research view
Fundamentals · SEC EDGAR · FY 2026-03-31
Revenue & Earnings — fiscal year
$4.2B
2022
$4.5B
2023
$5.1B
2024
$5.5B
2025
$5.9B
2026
Snapshot
SEC EDGAR · FY 2026-03-31Revenue$5.9B
Net Income$785.1M
Gross Profit$2.6B
Oper Income$1.1B
EPS (dil)$7.93
Rev/sh$60.82
FCF/sh$9.96
Book/sh$73.74
Gross M44.2%
Oper M18.6%
Profit M13.2%
FCF M16.4%
ROE10.9%
ROA7.3%
ROIC9.6%
R&D/Rev1.9%
Rev Y/Y8.7%
Rev 3Y CAGR9.4%
EPS Y/Y27.9%
EPS 3Y CAGR95.0%
FCF 3Y CAGR35.0%
Payout31%
Div/sh$2.46
Shs Chg Y/Y-0.4%
Current Ratio2.09
Quick Ratio1.54
Debt/Eq0.25
Int Coverage18.1×
Net Debt$1.4B
Total Debt$1.8B
Cash & Eq$439.6M
Total Assets$10.7B
Oper CF$1.3B
Capex$369.0M
Free CF$972.4M
Buybacks$235.5M
Equity$7.2B
Liabilities$3.5B
Shs Outstand0.10B
SectorTechnology
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 5 FY| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $4.2B | $4.5B | $5.1B | $5.5B | $5.9B |
| Gross Profit | $1.9B | $2.0B | $2.2B | $2.4B | $2.6B |
| Operating Income | $477.8M | $791.1M | $836.1M | $866.6M | $1.1B |
| Net Income | $242.9M | $105.8M | $380.1M | $616.1M | $785.1M |
| Diluted EPS | $2.48 | $1.07 | $3.81 | $6.20 | $7.93 |
| Operating Cash Flow | $684.8M | $756.9M | $973.3M | $1.1B | $1.3B |
| Free Cash Flow | $397.2M | $395.0M | $613.0M | $778.0M | $972.4M |
COMMUNITY · $STE0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.